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(Env)-mediated cross-linking of their cell surface re-Dimiter S. Dimitrov*
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Cholesterol depletion by methyl-b-cyclodextrin, whichBiology
NCI-FCRDC presumably disrupts rafts, inhibits HIV-1 infection and
syncytia formation (J. Hildreth, Johns Hopkins Univ.,National Institutes of Health
Building 469, Room 104 Baltimore, R. Blumenthal). A limited number of specific
GSL including Gb3 and GM3 promote entry of a broadPost Office Box B
Miller Drive range of HIV-1 isolates (R. Blumenthal) (Hug et al., 2000).
The role of rafts appears to be specific, as GSL areFrederick, Maryland 21702
required in the target but not in the Env-expressing cells
for fusion. Inhibitors of GSL biosynthesis affected Env-
mediated fusion and infection, and this was rescued byRecent advances in our understanding of the molecular
the addition of certain purified GSL. The GSL-depletedorganization of cell membranes, the atomic structure
cells lost the ability to induce conformational changesof viral proteins, and their interactions with receptor
in Env-expressing cells but retained the property ofmolecules have provided novel insights into the mecha-
allowing complexes between CD4, coreceptors (CCR5nisms of virus entry and raised hopes for better control
and CXCR4), and gp120 of the Env to form. Thus, sec-by new inhibitors, vaccines, and specific delivery tools.
ondary interactions between portions of gp120 and GSLThese developments were discussed in a lively fashion
could be required for the conformational changes in Envat the second Frederick meeting on the Cell Biology of
leading to assembly of the fusion complex. GSL mightViral Entry (May 7±10, Frederick, Maryland) organized
have a dual functionÐin addition to their role as raftby R. Blumenthal (NCI-FCRDC, Frederick) and E. Hunter
components they could also specifically interact with(Univ. of Alabama, Birmingham).
the Env. The role of rafts in this case could be to increase
the local concentrations and arrangement of the fusion
Membrane Structure: Role of Rafts in Virus Entry? complex components. The receptor for ecotropic mu-
Sphingolipids and/or glycosphingolipids (GSL) plus rine leukemia virus, CAT1, could be a ªraftº protein (X.
cholesterol can associate laterally to form membrane Lu and J. Silver, NIAID, Bethesda). Rafts may be also
microdomains termed rafts. Such lipid rafts could asso- involved in the fusion of Semliki Forest virus (SFV), which
ciate with specific proteins while excluding others and requires the presence of cholesterol and sphingolipid
may be involved in numerous cellular functions, includ- in the target membrane. Three regions in the SFV E1
ing membrane traffic, cell morphogenesis, and signaling subunit, all outside the fusion peptide, are involved in
(Simons and Ikonen, 1997). M. Edidin (Johns Hopkins the control of cholesterol dependence (M. Kielian, Albert
Univ., Baltimore) provided an overview of the field of Einstein College of Medicine, New York). Low pH trig-
membrane domains and critically addressed the funda- gered the E1 ectodomain association with target mem-
mental issue of the existence and properties of rafts. branes via insertion of its fusion peptide and led to a
Operational definitions of lipid domains include differen- strong E1 association with rafts, while the fusion peptide
tials in lateral diffusion between related lipid analogs of influenza was not in a raft domain.
and differential detergent solubility. Lipid domains are HIV-1 is a raft virus (J. Hildreth). It contains GPI-
small, mobile, unstable, and probably fluctuate in size anchored proteins (CD59 and Thy-1) and incorporates
and composition. They can be disrupted by vesicle traf- the ganglioside GM1, which partitions preferentially into
fic, while in turn the traffic can create dynamic yet persis- lipid rafts (Nguyen and Hildreth, 2000). The association
tent patches of membrane proteins and lipids that are of assembling HIV-1 with rafts appears to be dependent
not specific domains. Transmembrane signaling that is on the N-terminal region of Gag (A. Ono and E. Freed,
initiated by immunoreceptors such as T cell receptors NIAID, Bethesda). The role of virus membrane rafts for
and Fc receptors for immunoglobulins (Ig) appears to entry remains unclear. HIV-1 produced by cholesterol-
involve rafts (B. Baird, Cornell Univ., Ithaca). The IgE depleted cells was not infectious (J. Hildreth). The extent
receptor is phosphorylated by Lyn tyrosine kinase only of membrane fusion activity of influenza hemagglutinin
after antigen-mediated aggregation causes the recep- (HA) was related to the extent of its association with
tors to coalesce into rafts that contain the active kinase rafts (M. Kumar and J. Zimmerberg, NICHD, Bethesda).
(and possibly exclude phosphatases). Underscoring the Other experiments, however, suggested that HA associ-
dynamic nature of raft interactions is their regulation by ation with rafts was not needed for fusion (J. White,
stimulated F-actin, which appears to cause separation Univ. of Virginia, Charlottesville). Thus, some viruses
of aggregated IgE receptors and raft components, in- could contain rafts in their membranes and may or may
cluding Lyn, later in the sequence of cell signaling events not require rafts in the target membrane for efficient
(Holowka et al., 2000). Studies similar to these would entry. Some participants felt that more convincing evi-
allow potential raft mechanisms to be tested for stimu- dence for the importance of rafts in virus entry is needed,
lated viral entry that involves envelope glycoprotein but rafts were considered by many attendees as a fruitful
new avenue for further elucidation of the role of mem-
brane organization in virus entry.* E-mail: dimitrov@ncifcrf.gov
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Virus Receptors adaptation to CD4 as the biologically important receptor
Viruses have evolved to utilize cell surface molecules for development of disease in humans (Xiao et al., 1999).
for gaining access into the cell interior. A surprisingly Whether receptor molecules are available for viruses to
small number of proteins are exploited as receptors enter cells depends on the complex interplay between
by a large group of retrovirusesÐsimple type C and D expression, endocytosis, recycling, and degradation. CD4,
mammalian retroviruses (D. Kabat, Oregon Health Sci- CCR5, and CXCR4 contain inducible signals that, when
ences Univ., Portland). All of these receptors contain activated, lead to endocytosis through the clathrin-
multiple transmembrane sequences, consistent with mediated pathway (M. Marsh, Univ. College London,
their function as transporters of small soluble molecules. London). CXCR4 contains signals that appear to be rec-
Many viruses that were previously assigned to different ognized by different sets of adaptor proteins targeting
interference groups have been found to use the same the protein to clathrin-coated pits. These signals can be
receptor, suggesting that these viruses are highly activated through both ligand-dependent and ligand-
adapted to their receptors and probably evolved from independent mechanisms, unlike CCR5 for which only
a common ancestor. It appears that retroviruses and a ligand-dependent signal has been identified.
viruses in general are highly adapted to their receptors J. Sodroski (Harvard Medical School, Boston) re-
and cannot readily switch receptor types. ported the development and characterization of a new
For viruses that use proteins as receptors, promiscu- model system to study receptor molecules incorporated
ous use of multiple receptors only occurs within a family in lipid membranes surrounding solid particles (para-
of very closely related receptors. One example is the magnetic proteoliposomes). Paramagnetic proteolipo-
coreceptors for the immunodeficiency viruses, which somes are uniform in size, stable at a broad range of
are chemokine receptors or related orphans. A large salt concentrations and pH, and can be analyzed by
body of evidence suggests that CCR5 and CXCR4 are FACS. Their magnetic properties facilitate rapid buffer
the dominant coreceptors used in primary cells by HIV-1 exchange, and integral membrane proteins can be in-
(R. Doms, Univ. of Pennsylvania, Philadelphia). CCR8 serted into the lipid membrane in either orientation. They
may play a role in thymic infection and pathogenesis allowed incorporation of pure and properly oriented
(H. Golding, FDA, Bethesda). This chemokine receptor CCR5, which bound gp120-CD4 complexes and confor-
is expressed at the surface of primary thymocytes, and mation-dependent anti-CCR5 antibodies and was used
its ligand (I-309) partially inhibits productive HIV-1 infec- successfully to screen a recombinant phage display li-
tion of mature thymocytes. Macrophages and certain brary. D. Dimitrov discussed another approach based
U937 cell subclones exhibit inefficient fusion mediated on the use of protein G-Sepharose beads for attachment
by some X4 HIV-1 Env, e.g., IIIB, even though they ex- of CCR5 (or CXCR4) purified by immunoprecipitation.
press relatively high amounts of CXCR4. The fusion effi- CCR5 was in a conformation close to the native one as
ciency of these and other cells is correlated to the sur- evidenced by its ability to bind specifically soluble CD4-
face concentration of gp120-CD4-CXCR4 complexes gp120 complexes and RANTES that can be displaced
(D. Dimitrov) and CD4-CXCR4 complexes (H. Golding). by CD4-gp120.
The molecular mechanisms of inefficient complex for- Many cell surface molecules can bind viruses but lack
mation and differential HIV-1 entry are unknown but the ability to induce conformational changes required
could depend on the existence of distinct conforma- for entry. D. Littman (New York Univ., New York) dis-
tional states of HIV-1 coreceptors related to cell type- cussed the recent discovery that a C-type lectin (DC-
specific differential modifications, oligomerization, as- SIGN) is highly expressed on dendritic cells (DC) present
sociation with CD4 and/or other molecules (R. Doms). in mucosal tissues and binds to the HIV-1 envelope
In one case, glycosylation had a dramatic effect on core- glycoprotein gp120 (Geijtenbeek et al., 2000). DC-SIGN
ceptor function (C. Broder, USUHS, Bethesda). The re- promotes efficient infection in trans of cells that express
moval of the two N-linked glycosylation sites in CXCR4
CD4 and chemokine receptors. It may enhance the cap-
allows the protein to potentially serve as a universal
ture of HIV-1 in the periphery and facilitate its transport
coreceptor for both X4 and R5 laboratory adapted and
to secondary lymphoid organs rich in T cells, to enhanceprimary HIV-1 strains (Chabot et al., 2000). This alteration
infection in trans of these target cells. Binding of virus tocould unmask conserved structures shared by CXCR4
DC-SIGN may result in its internalization and protectionand CCR5.
from degradation or inactivation, so virus can reach TCCR5 and CXCR4 competition for CD4, e.g., in CEM-
cell zones safely. HIV-1 can incorporate the integrinsderived cells and macrophages, could affect their core-
LFA-1 and VLA-4, which, through interaction with theirceptor function (H. Golding) (Lee et al., 2000). However,
ligands ICAM-1 and VCAM-1, respectively, can increasetransfectant HeLa cell lines (developed by D. Kabat and
its infectivity by as much as two orders of magnitudeE. Platt), which express low to high levels of CCR5, low
(J. Hildreth) (Liao et al., 2000). Thus, interactions be-levels of CD4, and intermediate levels of CXCR4, did
tween cell molecules and their ligands can profoundlynot exhibit significant differences in their fusion with X4
enhance virus entry through facilitating attachment.Env-expressing cells (D. Dimitrov). A possible interpreta-
tion of these results is that coreceptor competition for
Virus Structure and Conformational ChangesCD4 is cell type-dependent and/or the affinity of some
Leading to EntryX4 gp120s complexes with CD4 for CXCR4 is higher
Virus structure is critical for binding to receptor(s) andthan the CCR5 affinity for CD4. The association of CD4
changes in conformation, which are the ªheartº of thewith CCR5 supports a model proposed previously by
entry machinery. A major recent advance was the solu-several investigators for the evolution of HIV-1 that in-
volves earlier use of CCR5 as primary receptor and later tion at 2.5 AÊ resolution of the X-ray crystal structure
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of an HIV-1 gp120 core complexed with a two-domain Changes in pH were not required for EnvA association
with membranes and virus entry. However, J. Youngfragment of human CD4 and an antigen-binding frag-
ment of an antibody that blocks chemokine-receptor (Univ. of Wisconsin at Madison, Madison) reported ob-
servations suggesting a pH-dependent entry mecha-binding (Kwong et al., 1998). The gp120 structure con-
sists of inner and outer domains connected by a con- nism for ALV-A and ALV-B: ALV seems to be stable in
cells treated with ammonium chloride and enters cellsserved bridging sheet, which is part of the coreceptor
binding site (W. Hendrickson, Columbia Univ., New only when the inhibitor has been removed; ALV Env
fuses cells together by a mechanism that required re-York). Recent refinements of the gp120 structure have
found order in several sites that were previously re- ceptor and low pH; and ALV particles that are preloaded
with retroviral receptor-ligand bridge proteins are rap-ported as disordered. The oligomeric structure of HIV-1
Env is currently unknown, but a theoretical model of the idly inactivated at low pH. The difference between his
conclusions and the data by P. Bates and J. White mayorientation of gp120 in trimeric Env suggests that CD4
molecules bind obliquely and their membrane-spanning be due to differences in the viruses used, native ALV
versus MLV pseudotypes, respectively, pH-enhancingportions are separated by at least 19 nm (Kwong et al.,
2000). The chemokine receptors, by contrast, bind to a effects, or differences in experimental conditions. These
observations suggest that ALV-A and ALV-B entry maysterically restricted surface close to the trimer axis. The
CD4-gp120 interaction is associated with large gp120 involve a unique example of ªprimingº of a viral fusion
protein to drive membrane fusion in response to lowconformational changes that probably involve exposure
of the bridging sheet and relative motions of the inner pH only after the high-affinity receptor interaction has
occurred. SFV requires low pH for fusion and like RSVand outer domains. E. Berger (NIAID, Bethesda) dis-
cussed a functional demonstration that CD4 binding (in the absence of Tva) is resistant to triggering by in-
creasing temperature, perhaps reflecting additional re-activates gp120 for interaction with coreceptorÐsoluble
CD4 can activate Env-expressing cells to fuse with tar- quirements for specific lipids or receptor interactions
(M. Kielian) (Gibbons et al., 2000).get cells expressing coreceptor but not CD4 (Salzwedel
et al., 2000). The conformational changes in the surface (SU) sub-
units are coupled to those in the transmembrane (TM)To characterize intermediate states of membrane-
associated Env subsequent to the gp120-CD4 interac- subunits of Envs by mechanisms that are poorly under-
stood. The RSV SU C terminus appears to play a role thattion, A. Dimitrov and R. Blumenthal developed a method
based on activation induced by CD4-CCR5 complexes can be substituted by mutations in the fusion peptide (P.
Bates). Destabilizing proline mutations lower the energyattached to beads. These complexes bound specifically
to Env-expressing cells and induced membrane destabi- required to activate simian parainfluenza virus 5 fusion
protein (SV5 F)-mediated fusion circumventing the re-lization. The substitution of target membranes with solid
surfaces allowed arrest of the fusion intermediate in a quirement for a homotypic binding protein to trigger
fusion (C. Russell, R. Paterson, and R. Lamb, Northwest-state before membrane merging. Another opportunity
for dissection of steps in the conformational changes ern Univ., Evanston).
Activation of Env from viruses belonging to diverseof the Env was provided by the analysis of a CD4-inde-
pendent virus from HIV-1/IIIB, termed IIIBx, which inter- families such as Orthomyxoviridae (Influenza), Retroviri-
dae (HIV-1, SIV, MMLV), and Filoviridae (Ebola) leads toacts directly with the chemokine receptor CXCR4 (Hoff-
man et al., 1999). Gp120 of a IIIBx clone (8x) exists in a TM intermediates containing coiled-coils. The SV5 F is
no exception to this rule (R. Lamb) (Baker et al., 1999).partially triggered but stable state in which the con-
served coreceptor-binding site is exposed (R. Doms). Its core complex is not present in the precursor molecule
F0, and significant conformational changes can occurIn this state, the V3 loop can change the specificity of
coreceptor use but does not alter CD4 independence, subsequent to cleavage of the protein (R. Dutch and R.
Lamb). Coiled-coils are probably also involved in theindicating that these properties can be separated. The
determinants for CD4 independence of the 8x gp120 RSV (P. Bates) and Respiratory Syncytial Virus (M. Del-
medico, Trimeris, Inc., Durham) entry. However, uponreside in both the V3 and V4/C4 domains and flank the
putative conserved chemokine receptor binding site (J. exposure to low pH the fusion (E1) protein of SFV forms
very stable trimers by a mechanism that may not involveHoxie, Univ. of Pennsylvania, Philadelphia) (LaBranche
et al., 1999). Binding of a single gp120 subunit to CD4 coiled-coils (M. Kielian) (Gibbons et al., 2000). These
data as well as data for the VSV G protein (H. Ghosh,and coreceptor can trigger a gp41 subunit on another
member of the oligomer to induce fusion, suggesting McMaster Univ., Hamilton) suggest that coiled-coils are
not universal components of protein fusion interme-another level of complexity in the gp120-gp41 coupling
following activation (E. Berger). diates.
After activation, membranes can induce further con-Unlike HIV, many viruses, including avian leucosis vi-
ruses (ALV) such as Rous sarcoma virus (RSV), utilize formational changes in the viral Env (Y. Shai, Weizmann
Institute of Science, Rehovot). Proteins correspondingone receptor capable of activating the entire entry pro-
cess. Tva can suffice as a receptor for RSV(A) based on to the ectodomain of gp41, but lacking the fusion pep-
tide, bind to membranes and dissociate, therein un-experiments with receptor pseudotyped virus, receptor-
induced activation of EnvA in vitro, and the ability of dergoing a major conformational change. Based on
these and other data (Peisajovich et al., 2000), Y. Shaisoluble Tva (sTva) to mediate infection (P. Bates, Univ.
of Pennsylvania, Philadelphia). In the presence of sTva, proposed that the membrane-induced conformational
changes cause the mutual approach of the viral andthe ectodomain of EnvA was rapidly and irreversibly
converted from a water-soluble form to a membrane- plasma membranes after the coiled-coil is formed. FHA2
construct derived from the first 127 residues of influenzaassociated form, likely representing its fusogenic state.
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HA induced liposome lipid mixing at low pH (Y. Shin, as shown recently by Markosyan, Cohen, and Melikyan
(2000); and (3) identification of intermediate states thatUniv. of California, Berkeley) (Epand et al., 1999). A G1E
mutation, which does not support fusion mediated by have characteristics of transitional hemifusion, e.g., at
elevated temperature they can proceed to fusion. Anfull-length HA2, abolished this effect. Y. Shin proposed a
possible fusion intermediate state for the FHA2-induced intermediate temperature arrested state was identified
that occurs after long incubation of HIV-1 Env-express-lipid mixing based on the hypothesis that the kinked
loop (amino acids 105±113) could cluster HA trimers at ing cells with CD41CXCR41 cells at 238C after the CD4-
gp120 interaction and rapidly converts to large fusionlow pH. Atomic force microscopy of FHA2 on lipid bi-
layers revealed extensive aggregation of the bound mol- pores upon increase of temperature to 378C (G. Melikyan
and F. Cohen). At physiological temperature, wild-typeecules upon acidification (R. Epand, McMaster Univ.,
Hamilton). Solid state NMR data suggest that when HA forms multiple transient hemifusion sites that are
present in the contact zone prior to an opening of thebound to membranes the gp41 fusion peptide becomes
more structured and adopts an extended conformation, first fusion pore (L. Chernomordik, NICHD, Bethesda)
(Leikina and Chernomordik, 2000). Lipid flow throughlikely due to oligomer formation (D. Weliky, Michigan
State Univ., East Lansing). The discussion reflected con- these sites was restricted by low pH-activated HA mole-
cules. These reversible hemifusion connections rapidlycerns regarding the appropriateness of isolated small
protein fragments for studying membrane fusion medi- disappeared after low pH application indicating that the
final low pH conformation of HA did not support mem-ated by complete protein molecules.
Nonenveloped viruses also require major conforma- brane merging. T. Stegmann (CNRS, Toulouse) reported
observations that small pores (,2.6 nm in diameter)tional changes for entry. When poliovirus is heated, the
virion undergoes an irreversible conformational transi- can be formed in liposomal membranes by whole virus,
purified HA, or HA ectodomains (Bonnafous and Steg-tion from the metastable state of the native 160S particle
to the 135S particle, which is believed to mediate entry mann, 2000). Based on these data, he proposed a new
model for fusion, in which HA initially forms a protein-into cells (J. Hogle, Harvard Medical School, Boston).
Similar conformational changes, including expulsion of aceous pore in the target but not in the viral membrane.
Y. Chizmadzhev (Russian Academy of Sciences, Mos-VP4 and externalization of the VP1 N-terminal arm, occur
upon binding to its receptor, Pvr, at physiological tem- cow) argued that membrane fusion pores should not
contain exposed hydrophobic regions. A lively discus-perature. Thus, Pvr serves as a catalyst that releases
the mature virion from a metastable state. The structures sion of differences between models of membrane fusion
intermediates suggested new ideas for future experi-of native virions and of two putative sequential entry
intermediates, the 135S and 80S particles, were recently ments.
The fact that GPI-linked proteins promote hemifusiondetermined at approximately 22 AÊ resolution (Belnap et
al., 2000). Domain movements of up to 0.9 nm were and not full fusion suggests an important role of the
membrane-spanning domains for completing the fusiondetected, which create gaps between adjacent sub-
units. The gaps at the sites where the VP1, VP2, and process. In line with this, an HA membrane-spanning
domain of 17 amino acids suffices to promote full fusion,VP3 subunits meet are plausible candidates for the
emergence of VP4 and the N terminus of VP1, which but one of 15 amino acids only supports hemifusion (J.
White). Although HA fusion is critically dependent oninsert into the membrane. These externalized compo-
nents form a transmembrane pore through which viral the length of this domain, lipid mixing, opening of small
aqueous pores, and subsequent pore enlargement doRNA enters the cell.
The concept that mature nonenveloped virions are in not depend on specific HA sequence motif (Kezerski et
al., 2000). The membrane-spanning domains of SIV Envmetastable states is applicable to Envs of enveloped
viruses such as influenza and SV5. However, for some also play an important role in the expansion of fusion
pores (E. Hunter). Using a series of one amino acidviruses, such as RSV (P. Bates) and SFV (M. Kielian),
increasing temperature was not sufficient to substitute residue truncations in the transmembrane portion of the
SIVmac239 TM glycoprotein, he identified a minimal TMfor activation. There were extensive discussions of how
best to quantitate the basic energetics of the conforma- length of 189 amino acids that still supports fusion and
infection. TMs further truncated to 186 and 185 aminotional changes required for the functioning of the entry
machinery. acids supported efficient incorporation into virions but
did not allow fusion although they were able to mediate
hemifusion and small pore formation as assessed by aViral Membrane Fusion
new three-color assay based on the use of an Env-BFPJ. Zimmerberg provided an overview of membrane fu-
construct. These results suggest TM function at multiplesion intermediates and discussed the role of hemifusion
stages of the entry processÐin addition to anchoringintermediates and membrane pores for fusion. HA fusion
the protein in the virus membrane and initiating theoccurs through a membrane hemifusion intermediate (J.
membrane fusion process, the TM plays a key role inWhite). Observations of hemifusion as an end stage are
later stages including the expansion of the fusion pore.not sufficient to prove its role as a fusion intermediate
(F. Cohen, Rush Medical College, Chicago). The evi-
dence that membrane fusion does involve hemifusion Virus Entry Inhibitors, Vaccines, and Retargeting
Although hundreds of compounds show HIV-1 entry in-intermediates includes (1) HA chimeras with a foreign
transmembrane (TM) domain support fusion; (2) GPI- hibitory activity in vitro, only one of them, DP178 (also
known as T-20), has been used successfully in clinicallinked HA is able to induce fusion pores in addition to
its well-known ability to promote end-state hemifusion settings (Kilby et al., 1998). The clinical evaluation of
Meeting Review
701
T-20 demonstrated that HIV-1 entry is a viable target for this protein as an immunogen alone and in complex with
antiretroviral therapy: T-20 was well tolerated over 28 CD4 and coreceptors are in progress. Strategies aimed
days, and the antiretroviral activity was dose dependent at eliciting antibodies that mimic CD4 in exposing the
and effective in heavily pretreated patients (M. Del- hidden epitopes plus antibodies that recognize the hid-
medico). New inhibitors (T-649 and T-1249) were devel- den epitopes might also lead to synergistic broadly neu-
oped that show higher potency against more primary tralizing activity (E. Berger). Yet another approach to elicit
isolates and have better resistance profiles in vitro than broadly reactive neutralizing antibodies is based on the
T-20. Peptides from heptad repeats of several other use of Envs from CD4-independent and deglycosylated
fusion proteins are also potent inhibitors of virus infec- gp120s where the coreceptor binding site is already
tions. Although the current hypothesis is that T-20 inhib- exposed (J. Hoxie, R. Doms). Neutralization of HIV-1 by
its by preventing the formation of the stable coiled- antibodies is a complex process and does not always
coil intermediate, determinants of coreceptor specificity correlate with antibody binding. Some CD4 T cell line
within the gp120 V3 loop can also modulate T-20 efficacy adapted (TCLA) and primary isolates (PI) bind equally
(C. Derdeyn, E. Hunter et al., Univ. of Alabama, Bir- well to specific neutralization antibodies but differ in
mingham). Yet another mechanism of T-20 inhibitory neutralization sensitivityÐTCLA were sensitive while the
effect was proposed based on its ability to interfere with parent primary isolates were resistant to neutralization
membrane fusion at a post lipid-mixing state (S. Gallo, (J. Nunberg).
R. Blumenthal, and Y. Shai). Cell-specific targeting is important for the use of viral
In a conceptually different line of reasoning, E. Berger vectors in gene-delivery applications. A bridge protein,
discussed the development of a recombinant protein comprised of the extracellular domain of the TVB recep-
containing sCD4 attached via a flexible polypeptide tor for subgroup B avian leukosis virus fused to epider-
linker to a single chain antibody against a conserved mal growth factor (EGF), allowed specific viral entry
CD4-induced epitope on gp120 involved in coreceptor when preloaded onto virions (J. Young) (Boerger et al.,
interaction. The protein is expected to potently neutral- 1999). MLV vectors in which the receptor binding domain
ize diverse HIV-1 strains. In another treatment approach (RBD) of the envelope surface glycoprotein was re-
aimed at eliminating HIV-infected cells that persist after placed with the hormone, erythropoietin (Epo), bound
antiretroviral therapy, he described an immunotoxin specifically to 293 cells expressing Epo receptor (J. Cun-
(3b3-PE) containing an affinity maturated single chain ningham, Harvard Medical School, Boston). After bind-
antibody against a conserved gp120 epitope linked to ing, infection was strongly activated by addition of puri-
the effector domains of Pseudomonas exotoxin A (PE). fied, soluble RBD to the cells. Infection required binding
This immunotoxin is much more potent than the pre- of RBD to its receptor, mCAT1, on the cell surface. These
viously developed sCD4-PE construct and may have experiments establish the conceptual possibility of tar-
lower in vivo toxicity. The inhibitory effect of a small geting infection by retroviral vectors to cells that express
molecule inhibitor of HIV-1 entry (TAK-779), which binds specific receptors.
to the extracellular surface of CCR5, was not dependent
on a single amino acid but instead was likely due to Future Perspectives
induced conformational change (T. Dragic, New York
The future remains bright for studies of virus entry. Rafts
Univ., New York, R. Doms) (Dragic et al., 2000). This
and their role in virus entry is a new challenging area
suggests the possibility of a new type of inhibitor that
of research. The combination of structural, moleculardoes not compete directly with gp120 for CCR5. Cells
biological, biochemical, and biophysical methodologiesexpressing the multidrug resistance gene product P gly-
undoubtedly will continue to provide novel insights intocoprotein display significant resistance to infection by
the function of the entry machinery. In the next decade,envelope viruses that invade cells by fusion with the
we will certainly witness the development of new clini-plasma membrane such as HIV-1 and Herpes Simplex
cally successful inhibitors of virus entry, vaccines basedVirus, suggesting an approach for inhibition of diverse
on modified Envs and Env-receptor complexes, and vi-virus infections (Y. Raviv, A. Puri, and R. Blumenthal).
rus-based delivery systems targeted to specific cellThe hypothesis that fusion intermediates expose con-
types.served epitopes seems to be supported by recent find-
ings that fusing cells elicited broadly neutralizing anti-
Acknowledgmentsbodies (LaCasse et al., 1999). D. Dimitrov discussed
an approach based on the use of purified Env-CD4-
I thank many of the meeting participants for their help in preparing
coreceptor complexes as alternative immunogens. this review and for allowing me to quote their unpublished results.
Gp120-CD4-CCR5 complexes were produced and used I am grateful to E. Berger, R. Blumenthal, R. Doms, H. Golding, L.
to immunize human CD4-CCR5 transgenic mice (D. Dim- Chernomordik, J. Cunningham, M. Kielian, and R. Lamb, whose
comments improved the entire review. I am in debt to C. Broder foritrov, X. Xiao, H. Goldstein, and C. Broder). The sera
helping me with the difficult task of revising the manuscript. I enjoyedfrom these animals contain anti-gp120 antibodies, and
the help of my daughter, Dimana, who again edited the manuscript.the neutralizing activity is under investigation. Similar
studies are in progress in the laboratory of J. Nunberg
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